Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Sell
2,729
-149
-5% -$12K 0.02% 281
2026
Q1
$204K Buy
2,878
+258
+10% +$19.3K 0.02% 271
2025
Q4
$207K Buy
2,620
+1
+0% +$79 0.02% 264
2025
Q3
$216K Sell
2,619
-134
-5% -$10.5K 0.02% 264
2025
Q2
$221K Buy
2,753
+1
+0% +$77 0.02% 241
2025
Q1
$221K Sell
2,752
-65
-2% -$5.41K 0.03% 227
2024
Q4
$231K Sell
2,817
-141
-5% -$11.7K 0.03% 221
2024
Q3
$244K Sell
2,958
-94
-3% -$7.02K 0.03% 231
2024
Q2
$214K Buy
3,052
+1
+0% +$71 0.03% 227
2024
Q1
$226K Buy
3,051
+1
+0% +$70 0.03% 224
2023
Q4
$202K Buy
+3,050
New +$191K 0.03% 235
2017
Q4
Sell
-4,308
Closed -$224K 157
2017
Q3
$224K Sell
4,308
-526
-11% -$25.6K 0.1% 133
2017
Q2
$237K Buy
+4,834
New +$224K 0.12% 102

Other funds holding MET

BFSG LLC's MET Position: Q2 2026 in Review

BFSG LLC reduced its MetLife (MET) stake by 5.2% in Q2 2026, selling an estimated $12K and leaving 2,729 shares worth $231K. The position accounts for 0.02% of the portfolio, ranked #281.

BFSG LLC first reported a position in MET in Q2 2017 and has held it in 13 quarters since. The position peaked at $244K in Q3 2024. 256 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • BFSG LLC held 2,729 shares of MetLife worth $231K as of Q2 2026.
  • BFSG LLC sold 149 MetLife shares in Q2 2026, an estimated $12K.
  • MetLife made up 0.02% of BFSG LLC's portfolio in Q2 2026, its #281 holding.
  • BFSG LLC first reported a position in MetLife in Q2 2017 and has held it in 13 quarters since.
  • BFSG LLC's MetLife position peaked at $244K in Q3 2024.
  • 256 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.